ConductScience.org, home
Papers
API referenceFor AI assistants

Paper629324

Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines.

Sorenson GD and 2 others. Am J Pathol, 1978. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines. Papers, record 629324. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/629324

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines.
PubMed
Journal
Am J Pathol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sorenson GDG D
2Pettengill OSO S
3Cate CCC C

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
Neoplasms, ExperimentalMajor topic
PlasmacytomaMajor topic
Animals
Cell Line
Clone Cells
Female
Immunity, Cellular
Mice

Source PubMed

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
214,221,803LOSS OF NEOPLASTIC PROPERTIES IN VITRO. I. OBSERVATIONS WITH S-180 CELL LINES.Cancer Res1964https://conductscience.org/library/papers/14221803PubMed
313,716,388Reduction of transplantability of Novikoff hepatoma cells grown in vitro and the consequent protecting effect to the host against their malignant progenitor.J Natl Cancer Inst1960https://conductscience.org/library/papers/13716388PubMed
8989,623Immunotherapy of cancer with antibody.Science1976https://conductscience.org/library/papers/989623PubMed
95,337,035Malignant transformation of cells in vitro.Int Rev Cytol1965https://conductscience.org/library/papers/5337035PubMed
104,695,794Loss and recovery of transplantability of L-P59 cells.In Vitro1973https://conductscience.org/library/papers/4695794PubMed
114,119,165Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.J Natl Cancer Inst1972https://conductscience.org/library/papers/4119165PubMed
124,358,536Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.Cancer Res1974https://conductscience.org/library/papers/4358536PubMed
134,360,637Spontaneous disappearance of tumorigenicity in a polyoma virus-induced neoplasm carried in vitro.Proc Soc Exp Biol Med1974https://conductscience.org/library/papers/4360637PubMed
144,336,548Morphologic and functional characteristics of long-term cultures of murine myeloma cells.Am J Pathol1972https://conductscience.org/library/papers/4336548PubMed
154,330,475Viral genome and oncogenic transformation: nuclear and plasma membrane events.Adv Cancer Res1971https://conductscience.org/library/papers/4330475PubMed
164,304,445Reversion in polyoma-transformed cells: retransformation, induced antigens and tumorigenicity.J Virol1969https://conductscience.org/library/papers/4304445PubMed
174,305,446The interaction of chemical carcinogens and cells in vitro.Prog Exp Tumor Res1969https://conductscience.org/library/papers/4305446PubMed
184,314,867The formation of variants with a reversion of properties of transformed cells. IV. Loss of detectable polyoma transplantation antigen.Virology1970https://conductscience.org/library/papers/4314867PubMed
194,625,122Cloning of mouse myeloma cells and detection of rare variants.J Cell Physiol1972https://conductscience.org/library/papers/4625122PubMed
204,571,237Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.J Natl Cancer Inst1973https://conductscience.org/library/papers/4571237PubMed
21128,571Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors.J Immunol1976https://conductscience.org/library/papers/128571PubMed
224,652,381Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro.J Natl Cancer Inst1972https://conductscience.org/library/papers/4652381PubMed
235,074,774The induction of immunoprotection by mouse ascites tumor cells attenuated in tissue culture.Eur J Cancer (1965)1972https://conductscience.org/library/papers/5074774PubMed
245,037,438Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment.J Natl Cancer Inst1972https://conductscience.org/library/papers/5037438PubMed
255,008,406Growth characteristics of long-term cultures of mouse myeloma cells.Exp Cell Res1972https://conductscience.org/library/papers/5008406PubMed

See all 26 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
3,902,300Implications of tumor progression on clinical oncology.Clin Exp Metastasis1985https://conductscience.org/library/papers/3902300PubMed
3,632,916Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3632916PubMed
2,908,825Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.Clin Exp Metastasis1989https://conductscience.org/library/papers/2908825PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/629324

GET https://conductscience.org/api/papers/v1/629324/references?page=2

API referenceFor AI assistants